Cameron Turtle
CIK 1758363 · Chief Executive Officer · last filed 2026-06-03
Cameron Turtle is a Chief Executive Officer who has filed 44 SEC Form 4 insider transactions across 6 companies since 2019. The most recent filing shows the insider sold $1.1M of SYRE on Jun 3, 2026. Across all open-market trades the lifetime net is −$17.8M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $50.4M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$50.42M
6
44
-$17.78M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SYRE | Chief Executive Officer | 597,540 | $80.79 | $48.28M | -$5.94M | 12 | 2026-06-03 |
| DMRA | Director | — | $20.78 | — | $0 | 1 | 2026-03-25 |
| ORKA | Director | — | $69.89 | — | $0 | 1 | 2025-06-03 |
| Spyre Therapeutics, Inc. (AGLE) Delisted | Chief Executive Officer | 746,507 | $12.01 | $8.97M | $0 | 1 | 2023-11-27 |
| BBIO | See Remarks | 32,068 | $66.80 | $2.14M | -$3.63M | 15 | 2020-12-29 |
| Eidos Therapeutics, Inc. (EIDX) Delisted | Chief Business Officer | 73,159 | — | — | -$8.21M | 13 | 2020-12-16 |
Recent Filings
44 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-03 | SYRE | Sell (S) | −15,000 | -$1.06M | EDGAR |
| 2026-05-01 | SYRE | Sell (S) | −15,000 | -$1.07M | EDGAR |
| 2026-04-03 | SYRE | Sell (S) | −15,000 | -$739.9K | EDGAR |
| 2026-03-25 | DMRA | Grant (A) | — | $0 | EDGAR |
| 2026-03-03 | SYRE | Sell (S) | −15,000 | -$632.9K | EDGAR |
| 2026-02-04 | SYRE | Sell (S) | −15,000 | -$492.0K | EDGAR |
| 2026-01-13 | SYRE | Grant (A) | — | $0 | EDGAR |
| 2026-01-06 | SYRE | Sell (S) | −15,000 | -$460.1K | EDGAR |
| 2025-12-03 | SYRE | Sell (S) | −15,000 | -$435.4K | EDGAR |
| 2025-11-05 | SYRE | Sell (S) | −45,000 | -$1.05M | EDGAR |